4α-TPA

4α-TPA Structure
4α-TPA structure
Common Name 4α-TPA
CAS Number 63597-44-4 Molecular Weight 616.83
Density 1.2±0.1 g/cm3 Boiling Point 698.1±55.0 °C at 760 mmHg
Molecular Formula C36H56O8 Melting Point N/A
MSDS Chinese USA Flash Point 208.1±25.0 °C

Differential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulation.

Br. J. Nutr. 112(1) , 8-14, (2014)

We have previously shown that curcumin (CUR) may increase lipid accumulation in cultured human acute monocytic leukaemia cell line THP-1 monocytes/macrophages, but that tetrahydrocurcumin (THC), an in vivo metabolite of CUR, has no such effect. In the present...

Protein kinase C-activating tumor promoters modulate the DNA damage response in UVC-irradiated TK6 cells.

Toxicol. Lett. 229(1) , 210-9, (2014)

12-O-Tetradecanoylphorbol-13-acetate (TPA) is a non-genotoxic tumor promoter that dysregulates the protein kinase C (PKC) pathway and causes variable cellular responses to DNA damage in different experimental models. In the present study, we pretreated human ...

Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway.

Mol. Carcinog. 54(2) , 134-47, (2015)

Rat mammary carcinoma susceptibility 5a1 (Mcs5a1), which is concordant to human MCS5A1 breast cancer risk locus, mediates susceptibility by a non-mammary cell-autonomous mechanism associated with T cell differential expression of F-box protein 10 (Fbxo10). Hu...

Drosophila MagT1 is upregulated by PKC activation.

Biochem. Biophys. Res. Commun. 436(2) , 140-4, (2013)

Magnesium transporter subtype 1 (MagT1) is a newly discovered and evolutionarily conservative magnesium membrane transporter with channel like properties. Previous reports have demonstrated that MagT1 is important to cellular magnesium homeostasis. In this st...

Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis.

Am. J. Physiol. Renal Physiol. 307(2) , F205-21, (2014)

Efficient clearance of apoptotic cells (efferocytosis) prevents inflammation and permits repair following tissue injury. Kidney injury molecule-1 (KIM-1) is a receptor for phosphatidylserine, an "eat-me" signal exposed on the surface of apoptotic cells that m...

Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.

Mol. Pharmacol. 86(4) , 406-16, (2014)

Biochemical high-throughput screening is widely used in drug discovery, using a variety of small molecule libraries. However, broader screening strategies may be more beneficial to identify novel biologic mechanisms. In the current study we used a β-galactosi...

Preparation of low molecular weight fucoidan by gamma-irradiation and its anticancer activity.

Carbohydr. Polym. 97(2) , 358-62, (2013)

Fucoidan is a marine sulfated polysaccharide with a wide variety of biological activities. Recently, it has been reported that low molecular weight fucoidan has the enhanced antioxidant and anticoagulative activities. However, degradation techniques such as e...

Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome.

Scand. J. Immunol. 79(1) , 37-42, (2014)

Epigenetic deregulation of genes encoded on the X chromosome as reported for CD40L in lupus could explain the female predominance of autoimmune diseases. We compared CD40L expression on CD4(+) T cells from primary Sjögren's syndrome (pSS) women and healthy co...

Phytosphingosine derivatives ameliorate skin inflammation by inhibiting NF-κB and JAK/STAT signaling in keratinocytes and mice.

J. Invest. Dermatol. 134(4) , 1023-32, (2014)

Phytosphingosine is abundant in plants and fungi and is found in mammalian epidermis, including the stratum corneum. Phytosphingosine and its derivatives N-acetyl phytosphingosine and tetraacetyl phytosphingosine are part of the natural defense system of the ...

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Nat. Med. 20(4) , 425-9, (2014)

HIV-1 persists in a latent reservoir despite antiretroviral therapy (ART). This reservoir is the major barrier to HIV-1 eradication. Current approaches to purging the latent reservoir involve pharmacologic induction of HIV-1 transcription and subsequent killi...